Pharmaceutical industry financial penalties in the U.S. 1991-2017, by violation type

This statistic represents the amount of money the pharmaceutical industry in the U.S. had to pay in financial penalties from 1991 to 2017, by type of violation. Over this time the pharmaceutical industry paid some 1.8 billion U.S. dollars in financial penalties due to poor manufacturing practices in which they sold drug products that failed to meet FDA standards or specifications.

Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation

In million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2018

Region

United States

Survey time period

1991 to 2017

Supplementary notes

* Since the publication of the 2016 report, an additional federal, non-qui-tam settlement with Syncor, in 2002 for $2.5 million ($0.5 million civil penalty; $2 million criminal penalty) for kickbacks, was found and added to the database.
** Settlements that involved more than one type of violation were reviewed and, where possible, individual penalties for each type of violation were determined and added to the totals for that violation. The final total for “multiple violations” represents the sum total that could not be (or was not) attributed to a single violation.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical and medical device recalls in the U.S."

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.